Showing results (31-40 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|December 9, 2023
The clinical efficacy of Olibanum gum chewing in patients with Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trialFereshteh Ghorat, Mahdi Sepidarkish, Farzaneh Saadattalab, et al.
Neuropsychopharmacology Reports|December 7, 2023
Quantification of cytosine modifications in the aged mouse brainHiroko Sugawara, Akitoshi Date, Satoshi Fuke, et al.
Neuropsychopharmacology Reports|November 21, 2023
The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic featuresChia-Chien Liu, Chen-Chia Lan, Ying-Sheue Chen
Neuropsychopharmacology Reports|November 6, 2023
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world dataYoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, et al.
Neuropsychopharmacology Reports|November 3, 2023
An adolescent boy with kleptomania and attention-deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case reportKensuke Miyazaki, Michiko Uchiyama
Neuropsychopharmacology Reports|November 2, 2023
Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control studyTzuyao Lo, Itaru Kushima, Hiroki Kimura, et al.
Neuropsychopharmacology Reports|November 6, 2023
Age-related cognitive decline is accelerated in alcohol use disorderKazuhiro Kurihara, Ayano Shiroma, Munenaga Koda, et al.
Neuropsychopharmacology Reports|November 10, 2023
Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in JapanTakao Kato, Nozomu Kotorii, Motohiro Ozone, et al.
Neuropsychopharmacology Reports|September 12, 2023
Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort studyYasushi Kawamata, Norio Sugawara, Taro Sasaki, et al.
Neuropsychopharmacology Reports|August 25, 2023
Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021)Satoshi Asakura, Naoki Yoshinaga, Hisashi Yamada, et al.
Pageof 66